  |
    |
|
|
      
|
|
The Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg) in Australia (the Criteria) has been developed to assist clinicians and transfusion medicine professionals to identify the conditions and circumstances for which the use of intravenous immunoglobulin (IVIg) is appropriate and funded under the National Blood Agreement. The Criteria supersedes the AHMAC IVIg Guidelines published in 2000.
The information and recommendations represent informed opinion based where possible, upon systematic review of the evidence. In the absence of published evidence, recommendations are based on clinical advice provided to the parties involved in developing this document (i.e. the Jurisdictional Blood Committee IVIg Working Party and its clinical advisers and consultants, the Jurisdictional Blood Committee, and the Commonwealth of Australia).
A Quick Reference Guide and Frequently Asked Questions have been developed to accompany the Criteria.
Copies of the Criteria and the Quick Reference Guide will be distributed to hospitals, professional colleges, governments and contributors on 3 March.
The Criteria and the Quick Reference Guide can be downloaded or viewed online by clicking on the appropriate links below. Alternatively, published copies of the Criteria and the Quick Reference Guide can be obtained from the NBA by completing the order request form below.
(2MB) (688KB) (518KB)For more information please contact the National Blood Authority by email at ivigcriteria@nba.gov.au
Privacy | Copyright | Disclaimer | Contact Us
This page last modified on 18 July, 2008
